Brand Name: TEKACORT®

Generic name: Clobetasol

Pharmaceutical category:
Corticosteroid medications.

Uses of:
Skin contact allergy, Short-term treatment of inflammation and itching of the skin caused by insect bite, Mild burns like sunburn, Atopic dermatitis, Contact dermatitis, Seborrhea dermatitis, Inflammatory dermatosis, Eczema ,etc.

The mechanism of Action:
Anti-inflammatory: TEKACORT® stimulates the production of the necessary enzymes to reduce the inflammatory response.
TEKACORT® from Group I is a potent effect of corticosteroids with fluorine that is commonly used in acute dermatosis treatment that has not responded to other corticosteroids with less potency.

Absorption: The amount of absorption of TEKACORT® depends on the strength of the effect of the product, the amount used and the position of the skin on the surface. The extent of TEKACORT® absorption is 1% in areas with a thick, horny layer of the skin (palms, palms, elbows and knees) up to 36% in areas with a thin horny layer (face, eyelids, and genital organs). In areas affected by skin, inflammation or dressing, the absorption of the drug increases. Local steroids, in particular, through oral mucosa, have a degree of systemic absorption.
Broadcast: After taking topical application, TEKACORT® is spread throughout the stomach. The amount of drug that absorbs the circulatory system is rapidly removed from the blood and spread into the muscles, liver, skin, intestines and kidneys.
metabolism: After taking topical application, TEKACORT® is metabolized predominantly in the skin. a little amount of the drug absorbed into the systemic circulation metabolizes to the inactive compounds in the liver.

It is not recommended in patients with more corticosteroids.

Avoid applying bandage or applying other coatings to the area under treatment.

Side effects:
More Common
– Burning or stinging at the application site
Less Common
– Burning sensation of the skin
– Dry skin
– Flushing or redness of the skin
– Itching, scaling, severe redness, soreness, or swelling of the skin
– Skin irritation
– Skin rash, encrusted, scaly and oozing
– Thinning of the skin with easy bruising, especially when used on the face or where the skin folds together (eg, between the fingers)
Thinning, weakness, or wasting away of the skin

Recommended Points:
Avoid contact with eyes.
The medication should not be used for more than 14 days.

Adults: It is applied topically twice a day (once in the morning and once in a night) on the affected skin.
Childs: TEKACORT® consumption in children younger than 12 years of age is not recommended.

Drug forms:
Topical Cream 0.05%
Local lotion: 0.05%
Topical Ointment: 0.05%

0.05% TEKACORT® ointment is available in the pharmaceutical basket of Pars Pharmed Company. Providing all documents related to the manufacture and analysis of this product to the Food and Drug Agency, the license and the export license was issued.